8Lummen G, Goepel M, Mollhoff S, et al. Phasell. Study of inteyferon- rversus interlcukin-2 and interferona-2b in metas-ticrenal cell carcinoma. J Urol, 1996,155:455.
9Atzpodien J, Hannien EL, Kirchner H, et al. Multinstitutional hometherapy trial of recombinant human interleukin-2 and interferon alpha-2 in progressive metastatic renal cell carcinoma. J Clin Oncol, 1995,13:997.
3[1]Mulder P, Figlin R, de Kemion LB, et al. Renal cell carcinoma:recent progress and future direction [J].Cancer Res, 1997, 57:5189-5195.
4[2]Yagoda A, Abi-Bached B, Petrylak D. Chemtherapy for advanced renal cell carcinoma:1983-1993[J]. Semin Oncol, 1995,22:42.
5[4]Yang JC, Topalian SL, Parkinson D, et al. Randomized comparision of high-dose and low-dose intravenous IL-2for the therapy of meta static renal cell carcinoma:an interim report[J]. J Clin Oncol, 1994,12:1572-1576.
6[5]Lopez hanninen E, Kirehner H, Atzpodien J. IL-2 bazed home therapy of merasratic RCC:risks and benefits in 215consecutive single institution patients [J].J Urol, 1996,158:19-25.
7王金万，实用肿瘤杂志，1991年，6期，206页
8胡清龙，实用肿瘤杂志，1990年，5期，60页
9Bukowski RM.Natural history and therapy of matastatic renal cell carcinoma,the role of interleukin-2 [J].Cancer,1997,80 (7):1198-1220.
10Buzio C,Palma GD,Passaiacqua R,et al.Effectiveness of very low doses of immunotherapy in advanced renal cell cancer[J].BrJ Cancer,1997,76(4): 541-544.
